13.16
Angiodynamic Inc stock is traded at $13.16, with a volume of 300.07K.
It is down -0.75% in the last 24 hours and up +9.48% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$13.26
Open:
$13.3
24h Volume:
300.07K
Relative Volume:
0.60
Market Cap:
$542.19M
Revenue:
$324.01M
Net Income/Loss:
$-192.37M
P/E Ratio:
-2.7531
EPS:
-4.78
Net Cash Flow:
$-23.46M
1W Performance:
-1.57%
1M Performance:
+9.48%
6M Performance:
+18.35%
1Y Performance:
+52.49%
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ANGO
Angiodynamic Inc
|
13.16 | 546.31M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
558.13 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
188.82 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.67 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.52 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.07 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - Defense World
AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance
Dynamic Technology Lab Private Ltd Purchases Shares of 29,317 AngioDynamics, Inc. $ANGO - MarketBeat
Buyback Watch: How rising interest rates impact AngioDynamics Inc. stockTrade Risk Summary & Weekly Top Performers Watchlists - BỘ NỘI VỤ
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO - Defense World
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO - Defense World
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Will AngioDynamics Inc. (UG2) stock maintain strong growthJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
[8-K] ANGIODYNAMICS INC Reports Material Event | ANGO SEC FilingForm 8-K - Stock Titan
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Fundação Cultural do Pará
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - Fundação Cultural do Pará
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Yahoo Finance
Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Insider Buying: Stephen Trowbridge Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List - Stock Titan
AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Stock (ANGO): Surges on Med-Tech Growth, Raises Outlook - Value The Markets
AngioDynamics (ANGO): Losses Worsen, but Forecasted 62% Earnings Growth Challenges Bearish Narratives - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):